Evidence map›Paper›PMID 31523744›Full record

ArticlePlant direct2019

Efficient and modular CRISPR-Cas9 vector system for

Darren R Mallett, Mingqin Chang, Xiaohang Cheng, Magdalena Bezanilla

Open access · goldAbstract read
In one paragraph

Article in Plant direct, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 61 citations in OpenAlex.

  1. The Importance of thePlants (Basel, Switzerland) · 2026
    Review
  2. Article
  3. TON1 and FASS are required to recruit myosin VIII, a cell division guidance factor.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Phenotype ofGenes · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. What can hornworts teach us?Frontiers in plant science · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Darren R MallettDepartment of Biological Sciences Dartmouth College Hanover New Hampshire.ORCID https://orcid.org/0000-0002-4505-5481
Mingqin ChangDepartment of Biological Sciences Dartmouth College Hanover New Hampshire.ORCID https://orcid.org/0000-0003-4238-9088
Xiaohang ChengDepartment of Biological Sciences Dartmouth College Hanover New Hampshire.ORCID https://orcid.org/0000-0003-3337-5418
Magdalena BezanillaDepartment of Biological Sciences Dartmouth College Hanover New Hampshire.ORCID https://orcid.org/0000-0001-6124-9916
Dartmouth College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CRISPR-Cas9 has been shown to be a valuable tool in recent years, allowing researchers to precisely edit the genome using an RNA-guided nuclease to initiate double-strand breaks. Until recently, classical RAD51-mediated homologous recombination has been a powerful tool for gene targeting in the moss

Indexed as

CRISPRgenome editinghomology‐directed repairmultiplexingPhyscomitrella patensvector system

Identifiers

PMID31523744
PMCPMC6739617
OpenAlexW2972842079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.